NHIF and Janssen Kenya seal a Partnership to Enhance Patient Access to Prostate Cancer Drugs

Press release by NHIF and Janssen Kenya  Prostate cancer patients covered by the National Hospital Insurance Fund (NHIF) can now access an innovator prescription drug manufactured and distributed by Janssen Kenya, one of the pharmaceutical companies of Johnson & Johnson, as part of a strategic